“There are likely genetic factors that affect an individual’s ability to lose weight,” said the doctor, who was not involved in the study. “Simply stated, despite similar efforts, caloric restriction ...

Gut‑hormone incretins (e.g., GLP‑1 agonists) are the fastest growing segment, forecast to expand at a 33.15% CAGR through ...

Levita Magnetics announced today that it received expanded FDA 510(k) clearance for its MARS (magnetic-assisted robotic ...

New clearance expands clinical use of the disruptive Dynamic Magnetic Positioning™ technology for liver retraction in bariatric and hiatal hernia ...

A new study reveals that bariatric surgery results in significantly greater weight loss compared to popular GLP-1 drugs.

A groundbreaking clinical trial underway at Fresno Heart & Surgical Hospital may transform the future of gastrointestinal surgery all with the help of ...

Johnson & Johnson MedTech has introduced the ETHICON 4000 Stapler, a surgical device for managing tissue complexities.

Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...

Using a medication outside of its prescribed method is always risky — and in this case, especially unnecessary,” Dr. Michael Snyder told The Post.

Gen Z is choosing gastric balloons over surgery for weight loss. This trending solution fits perfectly with their flexible, health-conscious lifestyles.